Meissner V, Dinkel A, Kron M, Schiele S, Jahnen M, Lakes J
J Behav Med. 2025; .
PMID: 40042752
DOI: 10.1007/s10865-025-00559-w.
Bratt O, Auvinen A, Arnsrud Godtman R, Hellstrom M, Hugosson J, Lilja H
BMJ Oncol. 2025; 2(1):e000039.
PMID: 39886507
PMC: 11203092.
DOI: 10.1136/bmjonc-2023-000039.
Albertsen P
BMJ Oncol. 2025; 2(1):e000168.
PMID: 39886484
PMC: 11203070.
DOI: 10.1136/bmjonc-2023-000168.
De Vrieze M, Al-Monajjed R, Boschheidgen M, Albers P
J Pers Med. 2024; 14(8).
PMID: 39202010
PMC: 11355119.
DOI: 10.3390/jpm14080818.
Liu X, Duan H, Liu S, Zhang Y, Ji Y, Zhang Y
Front Genet. 2024; 15:1387588.
PMID: 39149591
PMC: 11324495.
DOI: 10.3389/fgene.2024.1387588.
Risk-stratified multi-round PSA screening for prostate cancer integrating the screening reference level and subgroup-specific progression indicators.
Liu X, Zhang Y, Duan H, Yang L, Sheng C, Fan Z
Eur J Med Res. 2023; 28(1):257.
PMID: 37496058
PMC: 10369696.
DOI: 10.1186/s40001-023-01228-x.
Personalized strategies in population screening for prostate cancer.
Remmers S, Roobol M
Int J Cancer. 2020; 147(11):2977-2987.
PMID: 32394421
PMC: 7586980.
DOI: 10.1002/ijc.33045.
Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years: A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO)....
Kovac E, Carlsson S, Lilja H, Hugosson J, Kattan M, Holmberg E
JAMA Netw Open. 2020; 3(1):e1919284.
PMID: 31940039
PMC: 6991265.
DOI: 10.1001/jamanetworkopen.2019.19284.
[PSA screening and molecular markers].
Lakes J, Arsov C
Urologe A. 2019; 58(5):486-493.
PMID: 30874831
DOI: 10.1007/s00120-019-0900-y.
Erectile Dysfunction in 45-Year-Old Heterosexual German Men and Associated Lifestyle Risk Factors and Comorbidities: Results From the German Male Sex Study.
Hallanzy J, Kron M, Goethe V, Kohn F, Schmautz M, Arsov C
Sex Med. 2019; 7(1):26-34.
PMID: 30638828
PMC: 6377383.
DOI: 10.1016/j.esxm.2018.11.004.
Concordance and Discordance of Sexual Identity, Sexual Experience, and Current Sexual Behavior in 45-Year-Old Men: Results From the German Male Sex-Study.
Goethe V, Angerer H, Dinkel A, Arsov C, Hadaschik B, Imkamp F
Sex Med. 2018; 6(4):282-290.
PMID: 30274908
PMC: 6302220.
DOI: 10.1016/j.esxm.2018.08.001.
[Effect of performing a single PSA screening : The CAP trial].
Al-Monajjed R, Arsov C, Albers P
Urologe A. 2018; 57(9):1137-1138.
PMID: 29796696
DOI: 10.1007/s00120-018-0678-3.
Prostate cancer screening-when to start and how to screen?.
Kohestani K, Chilov M, Carlsson S
Transl Androl Urol. 2018; 7(1):34-45.
PMID: 29594018
PMC: 5861291.
DOI: 10.21037/tau.2017.12.25.
[Self-concept and erectile dysfunction in 45-year-old men : Results of a corollary study of the PROBASE trial].
Kogel A, Dinkel A, Marten-Mittag B, Baron J, Albers P, Arsov C
Urologe A. 2016; 55(10):1321-1328.
PMID: 27138634
DOI: 10.1007/s00120-016-0102-9.
[Structure of biobanks for urological research].
Hatiboglu G, Huber J, Herpel E, Popeneciu I, Nyarangi-Dix J, Teber D
Urologe A. 2014; 54(9):1256-60.
PMID: 25503899
DOI: 10.1007/s00120-014-3722-y.
Serum markers in prostate cancer detection.
Bratt O, Lilja H
Curr Opin Urol. 2014; 25(1):59-64.
PMID: 25393274
PMC: 4315142.
DOI: 10.1097/MOU.0000000000000128.
